BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BIVI BioVie Inc

休市中 08-23 16:00:00 EDT

3.23

-0.11

-3.29%

盘后3.30

+0.07+2.15%

19:06 EDT

最高3.45	最低3.18	成交量4.98万
今开3.40	昨收3.34	日振幅8.08%
总市值1,974万	流通市值1,193万	总股本611.17万
成交额16.16万	换手率1.35%	流通股本369.30万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BIVI","market":"US","secType":"STK","nameCN":"BioVie Inc","latestPrice":3.23,"timestamp":1724443200000,"preClose":3.34,"halted":0,"volume":49767,"hourTrading":{"tag":"盘后","latestPrice":3.2995,"preClose":3.23,"latestTime":"19:06 EDT","volume":452,"amount":1485.9725,"timestamp":1724454407293},"delay":0,"floatShares":3693007,"shares":6111676,"eps":-9.539477,"marketStatus":"休市中","marketStatusCode":7,"change":-0.11,"latestTime":"08-23 16:00:00 EDT","open":3.4,"high":3.45,"low":3.18,"amount":161631.918891,"amplitude":0.080838,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.539477,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"adjPreClose":3.34,"preHourTrading":{"tag":"盘前","latestPrice":3.23,"preClose":3.34,"latestTime":"08:00 EDT","volume":162,"amount":523.2904074,"timestamp":1724414406301},"postHourTrading":{"tag":"盘后","latestPrice":3.2995,"preClose":3.23,"latestTime":"19:06 EDT","volume":452,"amount":1485.9725,"timestamp":1724454407293},"volumeRatio":0.18847603668243865,"impliedVol":1.7183,"impliedVolPercentile":0.5105},"requestUrl":"/m/hq/s/BIVI/wiki","defaultTab":"wiki","newsList":[{"id":"2461182618","title":"Biovie Inc.盘中异动 大幅拉升8.38%报3.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461182618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461182618?lang=zh_cn&edition=full","pubTime":"2024-08-21 21:32","pubTimestamp":1724247121,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日21时32分，Biovie Inc.股票出现异动，股价急速拉升8.38%。截至发稿，该股报3.62美元/股，成交量4929股，换手率0.08%，振幅0.00%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408212132029f4336b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408212132029f4336b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2460733031","title":"Biovie Inc.盘中异动 急速拉升6.08%报3.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460733031","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460733031?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:31","pubTimestamp":1724074294,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时31分，Biovie Inc.股票出现异动，股价快速拉升6.08%。截至发稿，该股报3.45美元/股，成交量1.987万股，换手率0.32%，振幅0.00%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Cingulate Inc.较为活跃，换手率分别为1923.46%、1339.30%、296.30%，振幅较大的相关个股有Virax Biolabs Group Limited、Alzamend Neuro, Inc.、Theriva Biologics, Inc.，振幅分别为34.74%、34.31%、31.36%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819213134a1d503b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819213134a1d503b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BIVI","ALZN"],"gpt_icon":0},{"id":"2459477947","title":"Biovie Inc.盘中异动 急速拉升9.50%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459477947","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459477947?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:07","pubTimestamp":1723738031,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日00时07分，Biovie Inc.股票出现异动，股价快速上涨9.50%。截至发稿，该股报2.42美元/股，成交量2.9494万股，换手率0.48%，振幅4.07%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为1.34%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000712ab5ddcaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000712ab5ddcaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2459909226","title":"Biovie Inc.盘中异动 早盘大幅上涨9.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459909226","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459909226?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:30","pubTimestamp":1723555840,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时30分，Biovie Inc.股票出现异动，股价大幅拉升9.42%。截至发稿，该股报2.44美元/股，成交量5604股，换手率0.09%，振幅0.00%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321304098e34dc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321304098e34dc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2458986881","title":"Biovie Inc.盘中异动 早盘股价大涨6.65%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458986881","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458986881?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:31","pubTimestamp":1723469465,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时31分，Biovie Inc.股票出现异动，股价急速拉升6.65%。截至发稿，该股报2.65美元/股，成交量6469股，换手率0.11%，振幅3.63%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213106af97158f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213106af97158f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2457319521","title":"Biovie Inc.盘中异动 早盘股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457319521","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457319521?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:37","pubTimestamp":1723124275,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时37分，Biovie Inc.股票出现波动，股价快速拉升5.50%。截至发稿，该股报2.30美元/股，成交量2.2766万股，换手率0.37%，振幅2.29%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213755941ff747&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213755941ff747&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2457184194","title":"Biovie Inc.盘中异动 股价大跌6.06%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457184194","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457184194?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:40","pubTimestamp":1723038000,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时40分，Biovie Inc.股票出现波动，股价快速下跌6.06%。截至发稿，该股报2.17美元/股，成交量7.5327万股，换手率1.23%，振幅3.46%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.75%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080721400096824ca2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080721400096824ca2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2457404650","title":"Biovie Inc.盘中异动 早盘急速下跌13.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457404650","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457404650?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:32","pubTimestamp":1722951141,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时32分，Biovie Inc.股票出现异动，股价急速跳水13.58%。截至发稿，该股报2.54美元/股，成交量1.3001万股，换手率0.21%，振幅9.19%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062132219f143612&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062132219f143612&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2457773591","title":"Biovie Inc.盘中异动 快速跳水13.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457773591","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457773591?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:36","pubTimestamp":1722864966,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时36分，Biovie Inc.股票出现波动，股价大幅下跌13.22%。截至发稿，该股报0.312美元/股，成交量13.7022万股，换手率0.22%，振幅6.06%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为1.68%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213606957f308e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213606957f308e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2456238998","title":"Biovie Inc.盘中异动 股价大跌6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456238998","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456238998?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:05","pubTimestamp":1722607518,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日22时05分，Biovie Inc.股票出现波动，股价大幅跳水6.13%。截至发稿，该股报0.357美元/股，成交量15.303万股，换手率0.25%，振幅5.05%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.92%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802220518941fd953&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802220518941fd953&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2455096403","title":"Biovie Inc.盘中异动 股价大跌5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455096403","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455096403?lang=zh_cn&edition=full","pubTime":"2024-07-31 02:52","pubTimestamp":1722365578,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日02时52分，Biovie Inc.股票出现异动，股价快速跳水5.95%。截至发稿，该股报0.386美元/股，成交量35.8641万股，换手率0.59%，振幅7.32%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731025258941fbfc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731025258941fbfc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2455663692","title":"Biovie Inc.盘中异动 快速下挫6.17%报0.441美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455663692","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455663692?lang=zh_cn&edition=full","pubTime":"2024-07-29 21:34","pubTimestamp":1722260070,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日21时34分，Biovie Inc.股票出现波动，股价快速下挫6.17%。截至发稿，该股报0.441美元/股，成交量10.6664万股，换手率0.17%，振幅5.60%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Sangamo Therapeutics, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Palisade Bio, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1257.40%、142.72%、137.54%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为56.92%、41.37%、35.22%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072921343096821355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072921343096821355&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2454708008","title":"Biovie Inc.盘中异动 股价大涨5.50%报0.430美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454708008","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454708008?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:43","pubTimestamp":1721918594,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时43分，Biovie Inc.股票出现波动，股价快速拉升5.50%。截至发稿，该股报0.430美元/股，成交量23.0468万股，换手率0.38%，振幅6.53%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Exicure, Inc.、Psyence Biomedical Ltd.、Nutriband Inc C/Wts 涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Azitra Inc较为活跃，换手率分别为2474.65%、457.41%、201.09%，振幅较大的相关个股有Exicure, Inc.、Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.，振幅分别为132.26%、130.22%、98.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725224314941faa5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725224314941faa5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2453037365","title":"Biovie Inc.盘中异动 股价大跌8.37%报0.394美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453037365","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453037365?lang=zh_cn&edition=full","pubTime":"2024-07-23 21:31","pubTimestamp":1721741497,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日21时31分，Biovie Inc.股票出现波动，股价急速下跌8.37%。截至发稿，该股报0.394美元/股，成交量95.3881万股，换手率1.56%，振幅1.14%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072321313795533164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072321313795533164&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2453717305","title":"Biovie Inc.盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453717305","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453717305?lang=zh_cn&edition=full","pubTime":"2024-07-23 03:29","pubTimestamp":1721676547,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日03时29分，Biovie Inc.股票出现波动，股价急速上涨5.16%。截至发稿，该股报0.405美元/股，成交量27.4122万股，换手率0.45%，振幅5.99%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723032907aefacee5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723032907aefacee5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2450464108","title":"Biovie Inc.盘中异动 下午盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450464108","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450464108?lang=zh_cn&edition=full","pubTime":"2024-07-11 01:49","pubTimestamp":1720633755,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日01时49分，Biovie Inc.股票出现异动，股价急速上涨5.10%。截至发稿，该股报0.431美元/股，成交量9.3746万股，换手率0.15%，振幅4.75%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为1.33%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110149159681b982&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110149159681b982&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4007","VRPX","BK4139"],"gpt_icon":0},{"id":"2448986488","title":"Biovie Inc.盘中异动 股价大涨7.27%报0.434美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448986488","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448986488?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:31","pubTimestamp":1720013477,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时31分，Biovie Inc.股票出现波动，股价大幅拉升7.27%。截至发稿，该股报0.434美元/股，成交量4.6806万股，换手率0.08%，振幅3.14%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407032131179efc1aa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407032131179efc1aa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2448104359","title":"背景资料-礼来紧随百健-艾赛之后，获得美国食品及药物管理局对阿尔茨海默氏症药物的批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2448104359","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448104359?lang=zh_cn&edition=full","pubTime":"2024-07-03 20:18","pubTimestamp":1720009106,"startTime":"0","endTime":"0","summary":"     路透7月3日 -    礼来公司  的Kisunla周二获得了美国食品和药物管理局的标准批准，用于减缓阿尔茨海默氏症的进展。Kisunla是继百健  和日本卫材  的Leqembi之后，第二种获得美国监管机构传统批准的治疗脑萎缩疾病的药物，这在一个经历了多次失败的领域是一个重要的里程碑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708995401.HKD","ANVS","LGVN","LU0109391861.USD","IE0002141913.USD","IE0004445239.USD","BIVI","GB00BDT5M118.USD","BK7067","ACIU","LU0061475181.USD","LU2237438978.USD","LU2237443978.SGD","BK4533","LU1988902786.USD","ACW.AU","LU2237443622.USD","LU1804176565.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2237443549.SGD","LU0122379950.USD","CGTX","LU1057294990.SGD","COYA","LU2468319806.SGD","LU2491049909.HKD","LU1023059063.AUD","BK4532","LU1551013342.USD","LU2491050071.SGD","BK4007","IE00BJT1NW94.SGD","LU2264538146.SGD","LU0882574055.USD","IE00B19Z9P08.USD","IE00B1BXHZ80.USD","LU1280957306.USD","LLY","BK4534","LU0320765992.SGD","LU0943347566.SGD","LU1551013425.SGD","LU0058720904.USD","LU1814569148.SGD","LU2237443382.USD","BIIB","IE00B894F039.SGD","LU0079474960.USD","LU0256863811.USD"],"gpt_icon":0},{"id":"2448516993","title":"BioVie(BIVI.US)获ThinkEquity首次覆盖，给予买入评级, 目标价3.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448516993","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448516993?lang=zh_cn&edition=full","pubTime":"2024-07-01 18:52","pubTimestamp":1719831166,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2443675911","title":"Biovie Inc.盘中异动 早盘股价大跌5.00%报0.462美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443675911","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443675911?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:53","pubTimestamp":1718373215,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时53分，Biovie Inc.股票出现波动，股价大幅下挫5.00%。截至发稿，该股报0.462美元/股，成交量2.7525万股，换手率0.05%，振幅4.46%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061421533596814507&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061421533596814507&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","LGVN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioviepharma.com","stockEarnings":[{"period":"1week","weight":-0.0062},{"period":"1month","weight":-0.2068},{"period":"3month","weight":-0.2889},{"period":"6month","weight":-0.7263},{"period":"1year","weight":-0.9066},{"period":"ytd","weight":-0.7437}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioVie Inc.成立于2013年4月10日，是一家内华达州公司。该公司是一家临床阶段的公司，致力于开发创新药物疗法，以治疗慢性衰弱疾病，包括神经和神经退行性疾病以及肝脏疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.024941},{"month":2,"riseRate":0.5,"avgChangeRate":0.343428},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.007393},{"month":4,"riseRate":0.333333,"avgChangeRate":0.031293},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.1608},{"month":6,"riseRate":0.571429,"avgChangeRate":0.512357},{"month":7,"riseRate":0.571429,"avgChangeRate":0.416375},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.116596},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.163736},{"month":10,"riseRate":0.333333,"avgChangeRate":0.067701},{"month":11,"riseRate":0.5,"avgChangeRate":0.012606},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.089981}],"exchange":"NASDAQ","name":"BioVie Inc","nameEN":"BioVie Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioVie Inc(BIVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioVie Inc,BIVI,BioVie Inc股票,BioVie Inc股票老虎,BioVie Inc股票老虎国际,BioVie Inc行情,BioVie Inc股票行情,BioVie Inc股价,BioVie Inc股市,BioVie Inc股票价格,BioVie Inc股票交易,BioVie Inc股票购买,BioVie Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioVie Inc(BIVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}